MedMen Enterprises Inc. MMNFF MMEN has received a summary judgment in its favor on all counts in a lawsuit against Arizona-based Whitestar Solutions, LLC.
In March 2020, litigation was filed by Whitestar against MedMen in the Superior Court of Arizona, Maricopa County, related to a membership interest purchase and sale agreement governing the purchase of EBA Holdings, Inc. dba MedMen Scottsdale. Whitestar alleged fraudulent inducement and breach of contract, among other claims, and sought rescission of the underlying transaction or $60 million in alleged monetary damages. MedMen consistently maintained that the lawsuit and claims were baseless and without merit – and the judge agreed on all counts, cancelling the upcoming jury trial and stating that “no reasonable juror could conclude that Whitestar is entitled to relief on any of those claims.” The judge further ruled that as the prevailing party, MedMen is entitled to submit an application to recover attorneys’ fees and taxable costs from Whitestar.
“We’ve always maintained MedMen’s innocence in this matter, and are pleased to be formally exonerated,” stated Ed Record, MedMen’s CEO. “This is yet another baseless lawsuit MedMen has been party to in recent years, and we remain committed to vigorously defending the company and recovering attorneys’ fees when possible.”
MedMen is represented by Jennifer Catero and Steven Jerome of Snell & Wilmer in this matter.
Management changes
Tyson Rossi, chief strategy officer, is leaving MedMen, effective June 3, 2022. The company will fill the role internally.
“We thank Tyson for his leadership and contributions to MedMen,” stated Record. “We wish him all the best in his future endeavors. We are also thankful to have a strong bench of talent to fill these openings.”
Photo: Courtesy of Sasun Bughdaryan on Unsplash
Related News
Ascend Wellness Net Revenue Increased +28% YoY, Q1 2022 Financial Results And MedMen Settlement
Ascend Wellness Signs Term Sheet To Settle Lawsuit With MedMen & Buy Its NY Operations For $88M
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.